Nanotechnology is an interdisciplinary research field that integrates chemistry, engineering, biology, and medicine. Nanomaterials offer tremendous opportunity as well as challenges for researchers. Of course, cancer is one of the world's most common health problems, responsible for many deaths. Exploring efficient anticancer drugs could revolutionize treatment options and help manage cancer mortality. Nanomedicine plays a significant role in developing alternative and more effective treatment strategies for cancer theranostics. This book mainly focuses on the emerging trends using nanomaterials and nanocomposites as alternative anticancer material's. The book is divided into three main topic areas: how to overcome existing traditional approaches to combat cancer, applying multiple mechanisms to target the cancer cells, and how nanomaterials can be used as effective carriers. The contents highlight recent advances in interdisciplinary research on processing, morphology, structure, and properties of nanostructured materials and their applications to combat cancer.Cancer Nanotheranostics is comprehensive in that it discusses all aspects of cancer nanotechnology. Because of the vast amount of information, it was decided to split this material into two volumes. In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy, including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials and nano-antibodies. In the second volume, we discuss the nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nano-erythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, the safety of nano-biomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics.

Autorentext
Dr Muthupandian SaravananMuthupandian Saravanan Graduated in Microbiology from Madurai Kamaraj University, India and Doctorate with Specialization in Medical Microbiology and Nanomedicine from Sathyabama University, India. Thereafter, He did a Post-Doctoral Research fellowship focusing his research on Nano-biomaterials & their Biomedical Applications (2011-2012). Prior to postdoc, he worked as an Assistant Professor (SG), SRM University, and Department of Biotechnology for six Years, from 2005 -2011. Presently, Dr. Saravanan working as a Professor, Department of Pharmacology Saveetha Dental college, SIMATS, Chennai, India and worked as Associate Professor, Department of Medical Microbiology and Immunology, Division of Bio-medical Sciences, School of Medicine, College of Health Science, Mekelle University, Ethiopia (2012-2021). His Research Specialization: Development of Novel biomaterials Emerging and Re-emerging Infectious disease and Cancer. He has published more than 150 research paper in Peer-reviewed Journal including high impact Journal with more than 8000 citations and h-index of 42 and i10 index of 85 and also three edited books.  He has participated more than 75 National and International conferences, Reviewers of more than 100 international peer-reviewed journals and Guest editor/ Editors for various reputed PubMed and Scopus indexed journals. He has received many fellowships and awards notably, IET- Nanobiotechnology premium Awards two times continuously in the year 2019 and 2020, DST-SERC Young Scientist fellowship in 2011, International Fellowship Advanced Course on Diagnostics Sponsored by LSH&TM & Fondation Mérieux, in France 2013, International Fellowship Pertussis: biology, epidemiology and prevention meeting Sponsored by Fondation Mérieux & WHO in France 2014, International Union of Microbiological Societies (IUMS) travel grant in 2015 to Canada, International Fellowship "Advanced Course on Antibiotics (AdCAb) Sponsored by Institute of Pasteur and Fondation Mérieux France, 2016. His area of research includes Medical Microbiology, Antimicrobial Resistance, Nanomedicine, Nanomaterials to combat AMR and Cancer.
****Dr Hamed BarabadiHamed Barabadi (PharmD, PhD) works as an Assistant Professor at the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. He obtained his PhD at Shahid Beheshti University of Medical Sciences, Tehran, Iran, in 2019. He graduated as a Doctor of Pharmacy (PharmD) from Mazandaran University of Medical Sciences, Sari, Iran, in 2014. Prior to starting his PhD, he served as a pharmaceutical expert at the Food and Drug Administration at the Department of Inspection and Supervision in Golestan Province, Iran, for two years. He owns to his credit a number of research papers and book chapters in high quality peer-reviewed journals. He has received many awards such as IET- Nanobiotechnology premium Awards two times continuously in the year 2019 and 2020. He is Guest editor/Editor for various reputed indexed journals such as Current Nanomedicine, Nanoscience and Nanotechnology-Asia, Frontiers in Pharmacology, Biocell, etc. His research interests lie in the area of pharmaceutical nanobiotechnology, ranging from green synthesis, characterization and optimization of nanobiomaterials to their pharmaceutical potential evaluations such as anticancer, antimicrobial, antioxidant, etc. Moreover, he has collaborated actively with researchers in several other disciplines of pharmaceutical sciences, particularly the nanoformulation of drugs for drug delivery systems and nanomedicine.

Inhalt
Preface
Chapter 1: The Quest for Cancer Nanotheranostics: From Nanotechnology to Cancer Nanotechnology
Chapter 2: Targeted Nanotheranostics for Personalized Cancer Therapy
Chapter 3: Cancer-Targeted Nanotheranostics: Recent Advances and Future Perspectives
Chapter 4: Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics
Chapter 5: Nanoparticle-Based Biologic Mimetics for Cancer Nanotheranostics
Chapter 6: Emerging Theranostic Metal-Based Nanomaterials to Combat Cancer
Chapter 7: Emerging Protein and Peptide-Based Nanomaterials for Cancer Therapeutic
Chapter 8: Emerging Lipid-Based Nanomaterials for Cancer Theranostics
Chapter 9: Emerging Polymer-Based Nanomaterials for Cancer Therapeutic
Chapter 10: Emerging Porphyrin-Based Nanomaterials for Cancer Nanotheranostic
Chapter 11: Role of Micro and Nanomotors in Therapeutics and Diagnostics
Chapter 12: Bionanomaterials in Radiopharmaceuticals for Cancer Nanotheranostics
Chapter 13: Safety of Nanobiomaterials for Cancer Nanotheranostics
Chapter 14: Limitations of Current Cancer Nanotheranostics
Index

**List of Contributors (Most have confirmed):**Prof. Tomas J WebsterDepartment of Chemical Engineering, Nanomedicine Science and Technology Center, Northeastern University, Boston, MA, USA
Prof. Gholam Ali MansooriDepartments of Bio and Chemical Engineering, University of Illinois at Chicago, Chicago, IL, 60607-7052, USA Prof. Ali KhademhosseiniDepartment of Bioengineering, University of California-Los Angeles, Los Angeles, CA 90095, USA Dr. Omid FarokhzadLaboratory of Nanomedicine and Biomaterials, Brigham and Women's Hospital, Harvard Medical School, USA Prof. Hamid GhandehariDepartments of Pharmaceutics and Pharmaceutical Chemistry and Bioengineering, Utah University, USA
Prof. Xing-Jie LiangChinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biological Effects of Nanomaterials & Nanosafety, National Center for Nanoscience and Technology, China
Prof. Marianna FoldvariFaculty of Pharmaceutical Sciences, School of Pharmacy, Waterloo Univer…